# OnCo record itgb3 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/itgb3/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "itgb3" ;
  schema:name "ITGB3"@en ;
  schema:alternateName "integrin subunit beta 3"@en, "Integrin beta-3"@en, "CD61"@en, "GPIIIa"@en, "GP3A"@en, "ITGB3" ;
  schema:description "ITGB3 (Integrin beta-3) is a gene. The public catalogues list it as a drug target, and clinical evidence ties its variants to diagnosis, prognosis or drug response."@en ;
  schema:url <https://onco.cc/targets/itgb3/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6156>, <https://www.uniprot.org/uniprotkb/P05106/entry>, <https://www.ncbi.nlm.nih.gov/gene/3690>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000259207> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "other" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6156>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000259207>, <https://www.uniprot.org/uniprotkb/P05106/entry>, <https://www.ncbi.nlm.nih.gov/gene/3690> ;
  onco:related <https://onco.cc/collections/open-targets/> .